BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18227301)

  • 1. Pharmacological characterization of noroxymorphone as a new opioid for spinal analgesia.
    Lemberg KK; Siiskonen AO; Kontinen VK; Yli-Kauhaluoma JT; Kalso EA
    Anesth Analg; 2008 Feb; 106(2):463-70, table of contents. PubMed ID: 18227301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
    Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
    Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
    Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
    Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
    Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
    J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
    Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
    Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ciprofloxacin and gentamicin on spinal morphine-induced antinociception in rats.
    Luger TJ; Farkas W; Geisler H; Lorenz IH
    Basic Clin Pharmacol Toxicol; 2005 May; 96(5):366-74. PubMed ID: 15853929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
    Chen SR; Pan HL
    Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
    Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
    Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of hypogastric and pelvic nerves for conveying cystitis induced nociception in conscious rats.
    Meen M; Coudore-Civiale MA; Eschalier A; Boucher M
    J Urol; 2001 Jul; 166(1):318-22. PubMed ID: 11435893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
    Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the antinociceptive effect of oxycodone in male and female rats.
    Holtman JR; Wala EP
    Pharmacol Biochem Behav; 2006 Jan; 83(1):100-8. PubMed ID: 16434089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model.
    Haranishi Y; Hara K; Terada T; Nakamura S; Sata T
    Anesth Analg; 2010 Feb; 110(2):615-21. PubMed ID: 20081141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive role of galanin in the spinal cord of rats with inflammation, an involvement of opioid systems.
    Xiong W; Gao L; Sapra A; Yu LC
    Regul Pept; 2005 Dec; 132(1-3):85-90. PubMed ID: 16214241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete, asymmetric, and route-dependent cross-tolerance between oxycodone and morphine in the Dark Agouti rat.
    Nielsen CK; Ross FB; Smith MT
    J Pharmacol Exp Ther; 2000 Oct; 295(1):91-9. PubMed ID: 10991965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
    Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
    Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive property of intrathecal and intraperitoneal administration of a novel water-soluble isoindolin-1-one derivative, JM 1232 (-) in rats.
    Nishiyama T; Chiba S; Yamada Y
    Eur J Pharmacol; 2008 Oct; 596(1-3):56-61. PubMed ID: 18708047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat.
    Whiteside GT; Harrison JE; Pearson MS; Chen Z; Fundytus ME; Rotshteyn Y; Turchin PI; Pomonis JD; Mark L; Walker K; Broglé KC
    J Pharmacol Exp Ther; 2004 Aug; 310(2):793-9. PubMed ID: 15054116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effects of intrathecally administered celecoxib, a cyclooxygenase-2 inhibitor, in the tail flick test and the formalin test in rats.
    Nishiyama T
    Acta Anaesthesiol Scand; 2006 Feb; 50(2):228-33. PubMed ID: 16430547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.